Published in Proc Natl Acad Sci U S A on November 24, 2003
Motivations and methods for analyzing pulsatile hormone secretion. Endocr Rev (2008) 2.01
The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism. J Biol Chem (2009) 1.04
Circadian clock-coordinated hepatic lipid metabolism: only transcriptional regulation? Aging (Albany NY) (2010) 0.85
Noncanonical suppression of GH-dependent isoforms of cytochrome P450 by the somatostatin analog octreotide. J Endocrinol (2013) 0.81
Comprehensive identification of sexually dimorphic genes in diverse cattle tissues using RNA-seq. BMC Genomics (2016) 0.79
Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity. Mol Metab (2013) 0.78
Growth hormone-independent suppression of growth hormone-dependent female isoforms of cytochrome P450 by the somatostatin analog octreotide. Eur J Pharmacol (2013) 0.78
Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension. Mol Med (2015) 0.76
STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective. JAKSTAT (2015) 0.75
Inappropriate drug prescribing for the community-dwelling elderly. JAMA (1994) 7.33
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol (1986) 2.94
Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc Natl Acad Sci U S A (1991) 1.55
Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol (1992) 1.31
Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol (1995) 1.25
Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol (1968) 1.23
Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J (1992) 1.17
Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab (2002) 1.10
Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab (1998) 1.07
Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology (1999) 1.03
Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile. Mol Pharmacol (1996) 1.02
Decreased pulsatile release of growth hormone in old male rats. Endocrinology (1980) 1.02
Rat hepatic P450IIA and P450IIC subfamily expression using catalytic, immunochemical, and molecular probes. Methods Enzymol (1991) 0.99
Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J Pharmacol Exp Ther (2000) 0.95
Renaturalizing the sexually dimorphic profiles of circulating growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) (1991) 0.95
Regulation of liver-specific steroid metabolizing cytochromes P450: cholesterol 7α-hydroxylase, bile acid 6β-hydroxylase, and growth hormone-responsive steroid hormone hydroxylases. J Steroid Biochem Mol Biol (1992) 0.92
Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta (1991) 0.92
Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Mol Endocrinol (1991) 0.91
Signalling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology (1989) 0.90
Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J Biol Chem (1993) 0.90
Effect of age and gender on pharmacokinetics of atorvastatin in humans. J Clin Pharmacol (1996) 0.88
Neonatal phenobarbital-induced defects in age- and sex-specific growth hormone profiles regulating monooxygenases. Am J Physiol (1995) 0.88
Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J Clin Endocrinol Metab (1996) 0.88
Intrinsic signals in the sexually dimorphic circulating growth hormone profiles of the rat. Mol Cell Endocrinol (2001) 0.88
Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab (1996) 0.85
Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther (1994) 0.82
Dilution of the chemiluminescence reagents reduces the background noise on western blots. Biotechniques (1995) 0.82
Growth hormone and thyrotropin secretory profiles and provocative testing in aged rats. Neurobiol Aging (1990) 0.81
Effect of antiserum to rat growth hormone (GH)-releasing factor on physiological GH secretion in the female rat. Endocrinology (1991) 0.81
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin. Pharm Res (1992) 0.81
Age- and sex-related changes in the components of the hepatic microsomal mixed function oxidase system in Sprague-Dawley rats. Xenobiotica (1988) 0.79
Growth hormone secretory patterns in young, middle-aged and old female rats. Neuroendocrinology (1987) 0.79
Aging and growth hormone. Horm Res (1993) 0.79
Constitutive and inducible hepatic cytochrome P450 isoforms in senescent male and female rats and response to low-dose phenobarbital. Drug Metab Dispos (2003) 0.78
Middle-age alterations in the sexually dimorphic plasma growth hormone profiles: involvement of growth hormone-releasing factor and effects on cytochrome p450 expression. Drug Metab Dispos (2002) 0.78
Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats. J Pharmacol Exp Ther (1985) 0.78
Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Clin Pharmacol Ther (1997) 0.77
Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Life Sci (1991) 0.77
Induction of hepatic mixed function oxidases in senescent rodents. Exp Gerontol (1978) 0.77
[Aging and drug metabolism: alteration of liver drug metabolizing ability in male rats. Is it functional deterioration or feminization of the liver?]. Yakugaku Zasshi (1991) 0.77
A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology (2007) 1.02
Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther (2005) 0.98
Sex-dependent expression of seven housekeeping genes in rat liver. J Gastroenterol Hepatol (2006) 0.90
Neonatal phenobarbital imprints overexpression of cytochromes P450 with associated increase in tumorigenesis and reduced life span. FASEB J (2005) 0.90
Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s. Mol Cell Endocrinol (2004) 0.90
Inducibility of male-specific isoforms of cytochrome p450 by sex-dependent growth hormone profiles in hepatocyte cultures from male but not female rats. Drug Metab Dispos (2005) 0.87
Extensive sex- and/or hormone-dependent expression of rat housekeeping genes. Endocr Res (2012) 0.85
Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men. Endocrinology (2011) 0.85
Inadequacy of the Janus kinase 2/signal transducer and activator of transcription signal transduction pathway to mediate episodic growth hormone-dependent regulation of hepatic CYP2C11. Mol Pharmacol (2004) 0.84
Attenuated expression of episodic growth hormone-induced CYP2C11 in female rats associated with suboptimal activation of the Jak2/Stat5B and other modulating signaling pathways. Drug Metab Dispos (2007) 0.83
Noncanonical suppression of GH-dependent isoforms of cytochrome P450 by the somatostatin analog octreotide. J Endocrinol (2013) 0.81
Inherent sexually dimorphic expression of hepatic CYP2C12 correlated with repressed activation of growth hormone-regulated signal transduction in male rats. Drug Metab Dispos (2008) 0.81
Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat. Drug Metab Dispos (2007) 0.81
Inherent sex-dependent regulation of human hepatic CYP3A5. Br J Pharmacol (2013) 0.80
Sex-dependent expression of CYP2C11 in spleen, thymus and bone marrow regulated by growth hormone. Biochem Pharmacol (2007) 0.79
Phenobarbital-imprinted overinduction of adult constituent CYP isoforms. Pharmacology (2003) 0.79
Two low protein diets differentially affect food consumption and reproductive performance in pregnant and lactating rats and long-term growth in their offspring. J Nutr (2006) 0.78
Constitutive and inducible hepatic cytochrome P450 isoforms in senescent male and female rats and response to low-dose phenobarbital. Drug Metab Dispos (2003) 0.78
Growth hormone-independent suppression of growth hormone-dependent female isoforms of cytochrome P450 by the somatostatin analog octreotide. Eur J Pharmacol (2013) 0.78
Middle-age alterations in the sexually dimorphic plasma growth hormone profiles: involvement of growth hormone-releasing factor and effects on cytochrome p450 expression. Drug Metab Dispos (2002) 0.78
Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate. J Pharmacol Exp Ther (2002) 0.78
Intrasplenic transplantation of isolated adult rat hepatocytes: sex-reversal and/or suppression of the major constituent isoforms of cytochrome P450. Toxicol Pathol (2011) 0.77
Spurious observation of splenic cyp2b1 expression. Drug Metab Dispos (2003) 0.75